Considerable attention has been focused on the purine nucleoside, aden
osine, in the control of renal blood flow, epithelial transport, and r
enin secretion; however, surprisingly little attention has been direct
ed toward the renal effects of purine nucleotides such as adenosine tr
iphosphate (ATP). Recent studies utilizing in vivo micropuncture and i
n vitro techniques have demonstrated that renal vascular, epithelial,
and mesangial cells respond to extracellular ATP via mechanisms distin
ct from those elicited by adenosine. ATP vasoconstricts afferent but n
ot efferent arterioles whereas adenosine vasoconstricts both vascular
segments. Adenosine-mediated afferent arteriolar vasoconstriction is a
bolished by adenosine receptor antagonists, whereas the response to AT
P is enhanced. ATP-mediated vasoconstriction reaches a maximum within
seconds of exposure while the vasoconstriction induced by adenosine de
velops more slowly L-type calcium channel antagonists such as diltiaze
m or felodipine prevent the sustained afferent vasoconstriction produc
ed by ATP. Data from micropuncture experiments indicate that peritubul
ar capillary infusion of ATP reduces glomerular pressure and results i
n marked attenuation of the tubuloglomerular feedback mechanism, which
transmits signals from the macula densa to the afferent arteriole. Th
ese data support the existence of ATP-sensitive P-2 purinoceptors in t
he preglomerular microvasculature that contribute to the control of re
nal vascular function via activation of calcium channels.